Aarti Pharmalabs Ltd. - Research Center
543748 AARTIPHARM Group (B) BSE data
Add to watchlist
| Results | |
| Statement |
P&L
|
| More |
Profit loss account
(Rs crore)
| Mar ' 23 | Mar ' 22 | Mar ' 21 | |||
|---|---|---|---|---|---|
| Income | |||||
| Operating income | 1,511.25 | 941.02 | - | ||
| Expenses | |||||
| Material consumed | 759.17 | 491.80 | - | ||
| Manufacturing expenses | 282.54 | 167.97 | - | ||
| Personnel expenses | 122.16 | 79.98 | - | ||
| Selling expenses | 5.13 | 0.31 | - | ||
| Adminstrative expenses | 33.92 | 21.16 | - | ||
| Expenses capitalised | - | - | - | ||
| Cost of sales | 1,202.91 | 761.24 | - | ||
| Operating profit | 308.34 | 179.79 | - | ||
| Other recurring income | 1.28 | 2.51 | - | ||
| Adjusted PBDIT | 309.62 | 182.30 | - | ||
| Financial expenses | 20.49 | 11.34 | - | ||
| Depreciation | 55.77 | 37.23 | - | ||
| Other write offs | - | - | - | ||
| Adjusted PBT | 233.36 | 133.73 | - | ||
| Tax charges | 61.63 | 27.00 | - | ||
| Adjusted PAT | 171.73 | 106.73 | - | ||
| Non recurring items | - | - | - | ||
| Other non cash adjustments | - | - | - | ||
| Reported net profit | 171.73 | 106.73 | - | ||
| Earnigs before appropriation | 877.67 | 705.95 | -0.02 | ||
| Equity dividend | 18.13 | - | - | ||
| Preference dividend | - | - | - | ||
| Dividend tax | - | - | - | ||
| Retained earnings | 859.55 | 705.95 | -0.02 | ||
© 2023 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis